| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Joseph J Wakshlag, Wayne S Schwark, Kelly A Deabold, Bryce N Talsma, Stephen Cital, Alex Lyubimov, Asif Iqbal, Alexander Zakharo. Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract. Frontiers in veterinary science. vol 7. 2020-10-28. PMID:33102539. |
cannabidiol (cbd)-rich hemp extract use is increasing in veterinary medicine with little examination of serum cannabinoids. |
2020-10-28 |
2023-08-13 |
Not clear |
| Matthew T Welling, Lei Liu, Carolyn A Raymond, Tobias Kretzschmar, Omid Ansari, Graham J Kin. Complex Patterns of Cannabinoid Alkyl Side-Chain Inheritance in Cannabis. Scientific reports. vol 9. issue 1. 2020-10-27. PMID:31388099. |
complex patterns of cannabinoid alkyl side-chain inheritance in cannabis. |
2020-10-27 |
2023-08-13 |
Not clear |
| Matthew T Welling, Lei Liu, Carolyn A Raymond, Tobias Kretzschmar, Omid Ansari, Graham J Kin. Complex Patterns of Cannabinoid Alkyl Side-Chain Inheritance in Cannabis. Scientific reports. vol 9. issue 1. 2020-10-27. PMID:31388099. |
the cannabinoid alkyl side-chain represents an important pharmacophore, where genetic targeting of alkyl homologs has the potential to provide enhanced forms of cannabis for biopharmaceutical manufacture. |
2020-10-27 |
2023-08-13 |
Not clear |
| Lauren Singer, Hannah Tokish, Faith Park, Christine Campisi, Ruth L Milanai. The cannabidiol conundrum: potential benefits and risks of cannabidiol products for children. Current opinion in pediatrics. vol 32. issue 1. 2020-10-27. PMID:31833952. |
since the federal ban on hemp products was lifted in december 2018, cannabidiol (cbd), a nonpsychoactive cannabinoid derived from hemp, has become increasingly popular and accessible. |
2020-10-27 |
2023-08-13 |
Not clear |
| Sabrina Jones, Azure L Yarbrough, William E Fantegrossi, Paul L Prather, John M Bush, Anna Radominska-Pandya, Ryoichi Fujiwar. Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135). Pharmacology research & perspectives. vol 8. issue 1. 2020-10-23. PMID:32003945. |
synthetic cannabinoids (scbs), designer drugs marketed as legal alternatives to marijuana, act as ligands to cannabinoid receptors; however, they have increased binding affinity and potency, resulting in toxicity symptoms such as cardiovascular incidents, seizures, and potentially death. |
2020-10-23 |
2023-08-13 |
Not clear |
| Anees Bahji, Callum Stephenson, Richard Tyo, Emily R Hawken, Dallas P Seit. Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis. JAMA network open. vol 3. issue 4. 2020-10-23. PMID:32271390. |
prevalence of cannabis withdrawal symptoms among people with regular or dependent use of cannabinoids: a systematic review and meta-analysis. |
2020-10-23 |
2023-08-13 |
Not clear |
| John E Nielsen, Antoine D Rolland, Ewa Rajpert-De Meyts, Christian Janfelt, Anne Jørgensen, Sofia B Winge, David M Kristensen, Anders Juul, Frédéric Chalmel, Bernard Jégou, Niels E Skakkebae. Characterisation and localisation of the endocannabinoid system components in the adult human testis. Scientific reports. vol 9. issue 1. 2020-10-22. PMID:31537814. |
heavy use of cannabis (marijuana) has been associated with decreased semen quality, which may reflect disruption of the endocannabinoid system (ecs) in the male reproductive tract by exogenous cannabinoids. |
2020-10-22 |
2023-08-13 |
human |
| Taylor M Newman, Laya P Krishnan, Jessica Lee, Guy R Adam. Microbiomic differences at cancer-prone oral mucosa sites with marijuana usage. Scientific reports. vol 9. issue 1. 2020-10-20. PMID:31481657. |
marijuana smoke contains cannabinoids, immunosuppressants, and a mixture of potentially-mutagenic chemicals. |
2020-10-20 |
2023-08-13 |
Not clear |
| Zinah Zamil Al-Ghezi, Kathryn Miranda, Mitzi Nagarkatti, Prakash S Nagarkatt. Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways. Frontiers in immunology. vol 10. 2020-10-19. PMID:31497013. |
combination of cannabinoids, Δ9- tetrahydrocannabinol and cannabidiol, ameliorates experimental multiple sclerosis by suppressing neuroinflammation through regulation of mirna-mediated signaling pathways. |
2020-10-19 |
2023-08-13 |
mouse |
| Renandro de Carvalho Reis, Kelson James Almeida, Luciano da Silva Lopes, Cíntia Maria de Melo Mendes, Edson Bor-Seng-Sh. Efficacy and adverse event profile of cannabidiol and medicinal cannabis for treatment-resistant epilepsy: Systematic review and meta-analysis. Epilepsy & behavior : E&B. vol 102. 2020-10-19. PMID:31731110. |
the inclusion criteria were as follows: clinical studies with a longitudinal observational design and intervention using cannabinoid derivatives, especially cannabidiol and medicinal cannabis, whereby some results involved the frequency of epileptic seizures. |
2020-10-19 |
2023-08-13 |
Not clear |
| Matthew W Elmes, Lauren E Prentis, Luke L McGoldrick, Christopher J Giuliano, Joseph M Sweeney, Olivia M Joseph, Joyce Che, Gregory S Carbonetti, Keith Studholme, Dale G Deutsch, Robert C Rizzo, Steven E Glynn, Martin Kaczoch. FABP1 controls hepatic transport and biotransformation of Δ Scientific reports. vol 9. issue 1. 2020-10-16. PMID:31110286. |
fabp1 controls hepatic transport and biotransformation of Δ the increasing use of medical marijuana highlights the importance of developing a better understanding of cannabinoid metabolism. |
2020-10-16 |
2023-08-13 |
Not clear |
| Adeline L Goss, Michelle Camero. Cannabis and Cannabinoids for MS Symptoms. Annals of neurology. vol 87. issue 6. 2020-10-14. PMID:32320086. |
cannabis and cannabinoids for ms symptoms. |
2020-10-14 |
2023-08-13 |
Not clear |
| Marilyn A Huestis, Cristina Sempio, Matthew N Newmeyer, Maria Andersson, Allan J Barnes, Osama A Abulseoud, Benjamin C Blount, Jennifer Schroeder, Michael L Smit. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users. Journal of analytical toxicology. vol 44. issue 7. 2020-10-14. PMID:32369162. |
free and glucuronide urine cannabinoids after controlled smoked, vaporized and oral cannabis administration in frequent and occasional cannabis users. |
2020-10-14 |
2023-08-13 |
Not clear |
| Marilyn A Huestis, Cristina Sempio, Matthew N Newmeyer, Maria Andersson, Allan J Barnes, Osama A Abulseoud, Benjamin C Blount, Jennifer Schroeder, Michael L Smit. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users. Journal of analytical toxicology. vol 44. issue 7. 2020-10-14. PMID:32369162. |
all urine specimens from 11 frequent and 9 occasional cannabis users were analyzed for 11 cannabinoids for ~85 h by liquid chromatography with tandem mass spectrometry following controlled smoked, vaporized or oral 50.6 mg Δ9-tetrahydrocannabinol (thc) in a randomized, placebo-controlled, within-subject dosing design. |
2020-10-14 |
2023-08-13 |
Not clear |
| Marilyn A Huestis, Cristina Sempio, Matthew N Newmeyer, Maria Andersson, Allan J Barnes, Osama A Abulseoud, Benjamin C Blount, Jennifer Schroeder, Michael L Smit. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users. Journal of analytical toxicology. vol 44. issue 7. 2020-10-14. PMID:32369162. |
these urinary cannabinoid marker concentrations from occasional and frequent cannabis users following three routes of administration provide a scientific database to assess single urine concentrations in cannabis monitoring programs. |
2020-10-14 |
2023-08-13 |
Not clear |
| Kathleen Russell, Maureen Cahill, Karen G Duderstad. Medical Marijuana Guidelines for Practice: Health Policy Implications. Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners. vol 33. issue 6. 2020-10-13. PMID:31655786. |
this article reviews the endocannabinoid system, current state of legislation on medical marijuana, policy considerations, recent fda approval of a cannabis product for pediatric use, ncsbn national nursing guidelines for medical marijuana, and pediatric implications for nursing practice. |
2020-10-13 |
2023-08-13 |
Not clear |
| Peter McGarvey, Jiahao Huang, Matthew McCoy, Joshua Orvis, Yael Katsir, Nitzan Lotringer, Iris Nesher, Malcolm Kavarana, Mingyang Sun, Richard Peet, David Meiri, Subha Madhava. De novo assembly and annotation of transcriptomes from two cultivars of Cannabis sativa with different cannabinoid profiles. Gene. vol 762. 2020-10-08. PMID:32781193. |
de novo assembly and annotation of transcriptomes from two cultivars of cannabis sativa with different cannabinoid profiles. |
2020-10-08 |
2023-08-13 |
Not clear |
| Carla J Berg, Betelihem Getachew, Kim Pulvers, Steve Sussman, Theodore L Wagener, Christina Meyers, Amy Park, Sarah Dorvil, Akilah Patterson, Amber Weber, Rashelle B Hayes, Dianne C Barker, Lisa Henrikse. Vape shop owners'/managers' attitudes about CBD, THC, and marijuana legal markets. Preventive medicine reports. vol 20. 2020-10-03. PMID:32995147. |
over the past decade in the us there have been marked pivotal changes in the policy and retail environment regarding cannabinoids, particularly cannabidiol (cbd) and delta-9-tetrahydrocannabinol (thc). |
2020-10-03 |
2023-08-13 |
human |
| Samuel T Wilkinson, Rajiv Radhakrishnan, Deepak Cyril D'Souz. Impact of Cannabis Use on the Development of Psychotic Disorders. Current addiction reports. vol 1. issue 2. 2020-10-01. PMID:25767748. |
experimental studies reveal that cannabis, tetrahydrocannabinol (thc) and synthetic cannabinoids reliably produce transient positive, negative, and cognitive symptoms in healthy volunteers. |
2020-10-01 |
2023-08-13 |
human |
| Kenneth Blum, Marlene Oscar-Berman, Eric R Braverman, Marcelo Febo, Mona Li, Mark S Gol. Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-Reward. Journal of reward deficiency syndrome. vol 1. issue 1. 2020-10-01. PMID:26306328. |
changes in the laws have heightened interest and encouraged research into both cannabinoid products and the potential harms of cannabis use, addiction, and intoxication. |
2020-10-01 |
2023-08-13 |
Not clear |